Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Tilorone |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Non-steroidal anti-inflammatory agent |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cromoglicic acid (substance) |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
intoxication par un médicament anti-inflammatoire local |
Causative agent (attribute) |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Valdecoxib (substance) |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Budesonide (substance) |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Halcinonide (substance) |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alclometasone (substance) |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clobetasone (substance) |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mometasone (substance) |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Deflazacort (substance) |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluticasone propionate |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluticasone (substance) |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Liver derivative complex |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Desiccated liver preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Injectable liver preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing liver extract (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hepacon liver extract D 0.1mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Topical anti-inflammatory prep[1] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Topical anti-inflammatory prep[2] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Other preps for inflamed joints |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
agent anti-inflammatoire |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Liver derivative complex 25.5mg/mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ciclesonide |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing etanercept (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adalimunab 40mg/mL injection solution 1mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Etanercept 25mg powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
adalimumab 40mg injection solution 0.8mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing adalimumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing tumor necrosis factor alpha inhibitor (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cromoglicate sodium 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium cromoglycate 20mg inhalation capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium cromoglycate 20mg/2mL nebulization unit (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium cromoglycate 5mg inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium cromoglycate 5mg inhaler+spacer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium cromoglycate 5mg breath-actuated aerosol inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium cromoglycate+salbutamol 1mg/100micrograms inhaler+spacer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium cromoglycate+salbutamol 1mg/100micrograms inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cromoglicate sodium 40 milligram/1 milliliter conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cromolyn sodium 100mg/5ml oral concentrate solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium cromoglycate+isoprenaline sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing cromoglicate sodium and salbutamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium cromoglycate 2% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing sodium cromoglycate in oral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Inhaled sodium cromoglycate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing sodium cromoglycate in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cromoglicic acid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cromolyn sodium (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium cromoglycate [gastro-intestinal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium cromoglycate [asthma] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium cromoglycate compounds |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium cromoglycate [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium cromoglycate [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cromolyn sodium 20mg/2 mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cromolyn sodium 0.8mg/inh |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cromolyn sodium 20mg/amp solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cromolyn sodium 100mg/5mL gas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cromolyn sodium 5.2mg/spr solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cromolyn sodium 10mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cromolyn sodium 800mcg/inh |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cromolyn sodium 40mg/spr solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cromolyn sodium 8.1g spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cromolyn sodium 40mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cromolyn sodium 0.8mg/spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium cromoglicate 40 mg/mL eye solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ophthalmic cromolyn sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Etanercept 50mg powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium cromoglycate+xylometazoline hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Substance with tumor necrosis factor alpha inhibitor mechanism of action (substance) |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Liver extract |
Is a |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Local anti-infective and anti-inflammatory poisoning |
Causative agent (attribute) |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Otic anti-inflammatory preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anti-inflammatory agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|